Table 7.
After treatment
|
Before treatment
|
Kappa
|
P
value
|
|||
Type 1, 2
|
Type 3, 4
|
Type 5-7
|
||||
All patients | Type 1, 2 | 12 (35.3) | 2 (9.1) | 2 (6.9) | 0.175 | 0.006 |
Type 3, 4 | 18 (52.9) | 16 (72.7) | 19 (65.5) | |||
Type 5-7 | 4 (11.8) | 4 (18.2) | 8 (27.6) | |||
Group 1 | Type 1, 2 | 4 (23.5) | 2 (14.3) | 1 (8.3) | 0.061 | 0.448 |
Type 3, 4 | 12 (70.6) | 10 (71.4) | 9 (75.0) | |||
Type 5-7 | 1 (5.9) | 2 (14.3) | 2 (16.7) | |||
Group 2 | Type 1, 2 | 8 (47.1) | 0 (0) | 1 (5.9) | 0.26 | 0.005 |
Type 3, 4 | 6 (35.3) | 6 (75.0) | 10 (58.8) | |||
Type 5-7 | 3 (17.6) | 2 (25.0) | 6 (35.3) |
Group 1: Low fermentable oligo, di- and monosaccharides and polyols (FODMAP) diet + probiotic, Group 2: low fermentable oligo, di- and monosaccharides and polyols diet + placebo.